Difference between revisions of "Project:Updates Switch Tables"
From Psychiatrienet
(→Updates Switch Tables) |
(→August 2023) |
||
| Line 2: | Line 2: | ||
===== August 2023 ===== | ===== August 2023 ===== | ||
| − | * Antidepressants: Reviewed and updated switches from and to agomelatine, moclobemide and bupropion. | + | * Antidepressants: Reviewed and updated switches from and to agomelatine, moclobemide and bupropion (not finished). |
===== June 2023 ===== | ===== June 2023 ===== | ||
Revision as of 16:15, 4 August 2023
Contents
Updates Switch Tables
August 2023
- Antidepressants: Reviewed and updated switches from and to agomelatine, moclobemide and bupropion (not finished).
June 2023
- Antidepressants: Reviewed and updated switches from TCA to SSRI and SSRI to TCA (not finished)
February 2023
- Antidepressants: Reviewed and updated switches from SSRI to SSRI and SSRI to SNRI (not finished)
- Changed reference of literature in switch table
March 2022
- Antipsychotics: Certain long acting to long acting switches deleted.
- Antipsychotics: oral to different antipsychotic long acting deleted.
- Antipsychotics: added penfluridol
- Antipsychotics: added paliperidone extended release formulations (Xeplion, Trivecta, Byannli)
- Antipsychotics: ziprasidone moved to rest AP
- Antipsychotics: paliperidone moved from rest AP
- Introduced Updates Switch Tables page for informing users about changes on the Switchwiki
October 2021
- Antipsychotics: added group partial antagonists
If you any have suggestions, please send them to info@tijdstroom.nl. We are looking forward to your feedback.
